Cigarettes/Tobacco · Founded 1936 · www.godfreyphillips.com · BSE 500163 · NSE GODFREY PH · ISIN INE260B01028
No Notes Added Yet
Business
Godfrey Phillips India Ltd. (GPI) is a leading manufacturer of cigarettes and tobacco products in India. Its core business involves the production, marketing, and distribution of a wide range of cigarette brands. GPI also holds an exclusive license from Philip Morris International to manufacture and distribute Marlboro cigarettes in India. Beyond tobacco, the company has diversified into convenience retailing through its "24SEVEN" stores, confectionery products (under the "Fundoo" and "Smarties" brands), and chewing products. The company generates revenue primarily through the sale of its tobacco products, with contributions from its retail and confectionery segments.
Revenue Mix
Cigarettes and Tobacco Products: This is the dominant segment, accounting for the vast majority of the company's revenue. Key brands include Four Square, Red & White, Cavanders, and Marlboro (under license). This segment also includes cut tobacco.
Retail: Operated through its "24SEVEN" convenience store chain, offering groceries, ready-to-eat food, and various daily essentials. While growing, its revenue contribution is significantly smaller than the tobacco segment.
Confectionery: Includes chewing gum and candies under brands like Fundoo and Smarties. This segment's contribution to overall revenue is also minor.
Industry
The Indian cigarette industry is highly concentrated and heavily regulated. Godfrey Phillips India is the third-largest cigarette manufacturer in India, after ITC Ltd. (the market leader) and VST Industries Ltd. The industry faces high taxation, strict advertising bans, and graphic health warning mandates. GPI holds a significant market share in specific price segments and regions and benefits from its established brand portfolio and extensive distribution network, allowing it to compete effectively against larger and smaller players, as well as the unorganized sector.
MOAT
Brand Equity & Loyalty: Established brands like Four Square and Red & White have a loyal customer base due to the habit-forming nature of the product and decades of market presence. The Marlboro license further enhances its premium brand portfolio.
Extensive Distribution Network: A deep and wide pan-India distribution network, reaching numerous retail points, is a significant barrier to entry and costly to replicate.
Regulatory Barriers: The highly regulated nature of the tobacco industry (licensing, manufacturing, marketing restrictions) creates high entry barriers for new players, thus protecting existing incumbents.
Economies of Scale: As a large-scale manufacturer, GPI benefits from cost efficiencies in production and procurement.
Growth Drivers
Premiumization: Shifting consumer preferences towards higher-priced, premium cigarette brands can drive value growth despite potential volume stagnation or decline in the overall market.
Diversification into Non-Tobacco: Expansion of the "24SEVEN" convenience store chain and growth in the confectionery segment offer avenues for long-term diversification and revenue streams less susceptible to tobacco-specific regulations.
Export Markets: Opportunities to expand into international markets for its tobacco products.
Market Share Gains: Potential to gain market share through new product introductions, effective marketing, and leveraging its distribution network.
Risks
Regulatory & Taxation Risks: The most significant risk is continuous and escalating regulatory pressures, including excise duty hikes, stricter packaging and advertising norms, and public health campaigns. This can impact profitability and volumes.
Health Awareness & ESG Concerns: Increasing public health awareness about the harms of smoking and growing environmental, social, and governance (ESG) scrutiny on tobacco companies can deter investors and consumers.
Illicit Trade: High taxes on legal cigarettes often lead to a thriving illicit market for smuggled or counterfeit products, which impacts the volumes and profitability of organized players.
Competition: Intense competition from ITC Ltd., VST Industries Ltd., and the unorganized sector can pressure market share and pricing.
Dependence on Tobacco: Despite diversification efforts, the company remains heavily reliant on the tobacco segment, which faces long-term structural challenges.
Management & Ownership
Godfrey Phillips India is promoted by the Modi Group (K.K. Modi family). The promoter group holds a significant stake in the company. Philip Morris Products S.A. (a subsidiary of Philip Morris International) also holds a minority stake and has a long-standing relationship with GPI for the manufacture and distribution of Marlboro cigarettes in India. The management team comprises experienced professionals from the tobacco and consumer goods sectors, overseeing operations and strategic direction.
Outlook
Godfrey Phillips India operates in a challenging but resilient industry. The company benefits from strong brand equity, an extensive distribution network, and the premiumization trend within the cigarette market, which allows for value growth despite potential volume pressures. Its diversification into convenience retail and confectionery offers long-term growth avenues, though these segments currently contribute a small portion of overall revenue. However, the outlook is continually overshadowed by significant regulatory risks, including potential tax hikes, stricter anti-tobacco legislation, and rising public health consciousness. The ongoing threat from illicit trade and intense competition further adds to operational complexities. The company's ability to navigate these regulatory headwinds through effective pricing, brand management, and successful diversification will be key to its sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1488 | 1107 | 1359 | 1628 | 1893 | 1888 | 1813 | 1632 | 2190 | 3486 |
| Other Income | 57 | 65 | 45 | 51 | 47 | 78 | 77 | 37 | 45 | 46 |
| Total Income | 1545 | 1171 | 1404 | 1679 | 1940 | 1965 | 1890 | 1669 | 2235 | 3532 |
| Total Expenditure | 1260 | 916 | 1089 | 1351 | 1532 | 1619 | 1476 | 1318 | 1810 | 2933 |
| Operating Profit | 285 | 255 | 315 | 329 | 408 | 347 | 414 | 351 | 425 | 599 |
| Interest | 6 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 |
| Depreciation | 36 | 28 | 27 | 27 | 28 | 42 | 28 | 29 | 31 | 33 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 243 | 224 | 285 | 298 | 377 | 302 | 383 | 319 | 391 | 563 |
| Provision for Tax | 60 | 58 | 51 | 92 | 95 | 80 | 92 | 78 | 97 | 148 |
| Profit After Tax | 183 | 166 | 234 | 206 | 282 | 222 | 292 | 241 | 294 | 416 |
| Adjustments | 30 | 48 | -5 | 42 | 34 | 58 | 65 | 64 | 50 | 106 |
| Profit After Adjustments | 212 | 214 | 229 | 248 | 316 | 279 | 356 | 305 | 343 | 521 |
| Adjusted Earnings Per Share | 13.6 | 13.7 | 14.7 | 15.9 | 20.2 | 17.9 | 22.8 | 19.6 | 22 | 33.4 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2587 | 2331 | 2403 | 2326 | 2497 | 2877 | 2525 | 2688 | 3562 | 4018 | 5611 | 9121 |
| Other Income | 32 | 37 | 47 | 55 | 79 | 107 | 119 | 114 | 168 | 210 | 221 | 205 |
| Total Income | 2619 | 2368 | 2450 | 2380 | 2576 | 2983 | 2644 | 2802 | 3731 | 4228 | 5832 | 9326 |
| Total Expenditure | 2220 | 2007 | 2150 | 2067 | 2094 | 2285 | 1984 | 2054 | 2759 | 3115 | 4434 | 7537 |
| Operating Profit | 398 | 360 | 300 | 313 | 482 | 698 | 660 | 747 | 972 | 1113 | 1398 | 1789 |
| Interest | 19 | 10 | 4 | 2 | 1 | 30 | 31 | 34 | 29 | 14 | 12 | 12 |
| Depreciation | 108 | 107 | 98 | 98 | 99 | 155 | 141 | 145 | 154 | 108 | 124 | 121 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 271 | 244 | 199 | 233 | 383 | 514 | 487 | 568 | 873 | 1152 | 1471 | 1656 |
| Provision for Tax | 89 | 74 | 62 | 74 | 123 | 129 | 111 | 130 | 182 | 225 | 318 | 415 |
| Profit After Tax | 183 | 170 | 137 | 159 | 260 | 385 | 376 | 438 | 690 | 926 | 1153 | 1243 |
| Adjustments | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43 | -81 | 285 |
| Profit After Adjustments | 183 | 170 | 137 | 159 | 260 | 385 | 377 | 438 | 690 | 883 | 1072 | 1525 |
| Adjusted Earnings Per Share | 11.8 | 10.9 | 8.8 | 10.2 | 16.7 | 24.7 | 24.1 | 28.1 | 44.3 | 56.6 | 68.7 | 97.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 40% | 28% | 14% | 8% |
| Operating Profit CAGR | 26% | 23% | 15% | 13% |
| PAT CAGR | 25% | 38% | 25% | 20% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -19% | 58% | 48% | 23% |
| ROE Average | 24% | 23% | 20% | 16% |
| ROCE Average | 31% | 29% | 26% | 21% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1313 | 1576 | 1660 | 1793 | 2039 | 2187 | 2582 | 2928 | 3548 | 4232 | 5246 |
| Minority's Interest | 4 | 44 | 40 | 37 | 33 | 29 | 5 | 5 | 5 | 6 | 7 |
| Borrowings | 31 | 27 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Non-Current Liabilities | 36 | 58 | 74 | 71 | 56 | 365 | 353 | 345 | 374 | 390 | 284 |
| Total Current Liabilities | 672 | 454 | 433 | 563 | 738 | 713 | 791 | 822 | 1040 | 1214 | 1421 |
| Total Liabilities | 2057 | 2159 | 2208 | 2465 | 2866 | 3295 | 3732 | 4102 | 4968 | 5843 | 6969 |
| Fixed Assets | 675 | 695 | 695 | 641 | 686 | 1006 | 1025 | 947 | 897 | 859 | 692 |
| Other Non-Current Assets | 401 | 448 | 498 | 855 | 1093 | 1233 | 1183 | 1506 | 2652 | 2973 | 3275 |
| Total Current Assets | 981 | 1012 | 1012 | 969 | 1087 | 1057 | 1524 | 1649 | 1419 | 2012 | 2995 |
| Total Assets | 2057 | 2159 | 2208 | 2465 | 2866 | 3295 | 3732 | 4102 | 4968 | 5843 | 6969 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 10 | 11 | 15 | 11 | 23 | 31 | 32 | 28 | 34 | -12 | -25 |
| Cash Flow from Operating Activities | 63 | 319 | 245 | 516 | 362 | 375 | 310 | 479 | 736 | 290 | 107 |
| Cash Flow from Investing Activities | -32 | -119 | -125 | -405 | -310 | -72 | -298 | -234 | -541 | 55 | 402 |
| Cash Flow from Financing Activities | -31 | -197 | -125 | -99 | -43 | -303 | -16 | -238 | -206 | -359 | -491 |
| Net Cash Inflow / Outflow | 1 | 3 | -4 | 12 | 9 | 0 | -4 | 6 | -11 | -13 | 18 |
| Closing Cash & Cash Equivalent | 11 | 13 | 11 | 23 | 31 | 32 | 28 | 34 | 23 | -25 | -7 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 11.75 | 10.88 | 8.8 | 10.2 | 16.69 | 24.67 | 24.14 | 28.08 | 44.27 | 56.61 | 68.73 |
| CEPS(Rs) | 18.64 | 17.72 | 15.05 | 16.51 | 23.01 | 34.62 | 33.19 | 37.39 | 54.11 | 66.34 | 81.84 |
| DPS(Rs) | 2.67 | 2.67 | 2.67 | 2.67 | 3.33 | 8 | 8 | 9.33 | 14.67 | 18.67 | 31.67 |
| Book NAV/Share(Rs) | 84.15 | 101.03 | 106.45 | 114.97 | 130.7 | 140.23 | 165.54 | 187.69 | 227.46 | 271.03 | 336.05 |
| Core EBITDA Margin(%) | 8.23 | 7.58 | 5.74 | 8.63 | 14.89 | 18.75 | 18.16 | 19.5 | 18.74 | 18.26 | 17.34 |
| EBIT Margin(%) | 6.52 | 5.95 | 4.6 | 7.84 | 14.19 | 17.23 | 17.38 | 18.54 | 21.03 | 23.57 | 21.84 |
| Pre Tax Margin(%) | 6.09 | 5.71 | 4.51 | 7.78 | 14.15 | 16.28 | 16.35 | 17.49 | 20.35 | 23.29 | 21.66 |
| PAT Margin (%) | 4.1 | 3.98 | 3.1 | 5.31 | 9.62 | 12.2 | 12.63 | 13.48 | 16.1 | 18.73 | 16.98 |
| Cash Profit Margin (%) | 6.53 | 6.48 | 5.32 | 8.6 | 13.26 | 17.12 | 17.37 | 17.95 | 19.69 | 20.93 | 18.8 |
| ROA(%) | 9.15 | 8.05 | 6.27 | 6.81 | 9.77 | 12.49 | 10.71 | 11.18 | 15.22 | 17.14 | 18 |
| ROE(%) | 14.62 | 11.75 | 8.46 | 9.21 | 13.58 | 18.21 | 15.79 | 15.9 | 21.32 | 23.83 | 24.35 |
| ROCE(%) | 19.27 | 15.41 | 11.78 | 13.21 | 19.68 | 25.41 | 21.33 | 21.44 | 27.56 | 29.65 | 31.05 |
| Receivable days | 9.56 | 10.17 | 11.87 | 16.14 | 10.42 | 7.95 | 11.75 | 15.6 | 12.95 | 11.9 | 18.52 |
| Inventory Days | 54.65 | 63.36 | 57.48 | 75.42 | 82.73 | 76.9 | 87.62 | 88.31 | 74.78 | 87.46 | 92.41 |
| Payable days | 49.58 | 46.75 | 39.97 | 50.11 | 78.34 | 78.67 | 72.69 | 72.37 | 63.35 | 63.99 | 50.24 |
| PER(x) | 12.04 | 36.42 | 42.93 | 26.83 | 23.16 | 12.73 | 12.6 | 11.99 | 13.7 | 18.18 | 32.8 |
| Price/Book(x) | 1.68 | 3.92 | 3.55 | 2.38 | 2.96 | 2.24 | 1.84 | 1.79 | 2.67 | 3.8 | 6.71 |
| Dividend Yield(%) | 1.88 | 0.67 | 0.71 | 0.97 | 0.86 | 2.55 | 2.63 | 2.77 | 2.42 | 1.81 | 1.4 |
| EV/Net Sales(x) | 0.95 | 2.69 | 2.47 | 1.83 | 2.41 | 1.69 | 1.89 | 1.95 | 2.65 | 4 | 6.27 |
| EV/Core EBITDA(x) | 6.17 | 17.42 | 19.75 | 13.59 | 12.5 | 6.96 | 7.23 | 7 | 9.73 | 14.44 | 25.15 |
| Net Sales Growth(%) | 4.36 | -9.91 | 3.09 | -3.2 | 7.38 | 15.19 | -12.21 | 6.42 | 32.55 | 12.79 | 39.64 |
| EBIT Growth(%) | 0.83 | -12.49 | -20.07 | 15.77 | 63.78 | 41.6 | -4.62 | 16.22 | 49.72 | 29.25 | 27.29 |
| PAT Growth(%) | 4.41 | -7.04 | -19.16 | 16.2 | 63.89 | 47.84 | -2.04 | 16.35 | 57.63 | 34.17 | 24.46 |
| EPS Growth(%) | 4.43 | -7.45 | -19.12 | 15.94 | 63.61 | 47.85 | -2.17 | 16.35 | 57.62 | 27.89 | 21.4 |
| Debt/Equity(x) | 0.21 | 0.08 | 0.04 | 0.02 | 0.02 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Current Ratio(x) | 1.46 | 2.23 | 2.34 | 1.72 | 1.47 | 1.48 | 1.93 | 2 | 1.37 | 1.66 | 2.11 |
| Quick Ratio(x) | 0.35 | 0.6 | 0.83 | 0.69 | 0.61 | 0.52 | 0.99 | 1 | 0.47 | 0.47 | 0.7 |
| Interest Cover(x) | 15.16 | 25.07 | 56.88 | 140.63 | 396.75 | 17.99 | 16.8 | 17.74 | 31.08 | 84.97 | 120.45 |
| Total Debt/Mcap(x) | 0.13 | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0.02 | 0.01 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 |
| FII | 10.13 | 10.77 | 10.83 | 10.8 | 10.63 | 9.73 | 9.32 | 7.94 | 8.15 | 7.91 |
| DII | 1.61 | 1.58 | 1.95 | 2.02 | 2.03 | 3.33 | 3.9 | 4.14 | 4.23 | 3.31 |
| Public | 15.69 | 15.07 | 14.64 | 14.61 | 14.76 | 14.36 | 14.2 | 15.34 | 15.03 | 16.2 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 11.32 | 11.32 | 11.32 |
| FII | 0.53 | 0.56 | 0.56 | 0.56 | 0.55 | 0.51 | 0.48 | 1.24 | 1.27 | 1.23 |
| DII | 0.08 | 0.08 | 0.1 | 0.1 | 0.11 | 0.17 | 0.2 | 0.65 | 0.66 | 0.52 |
| Public | 0.82 | 0.78 | 0.76 | 0.76 | 0.77 | 0.75 | 0.74 | 2.39 | 2.35 | 2.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 15.6 | 15.6 | 15.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +40% | +28% | +14% | +8% |
| Operating Profit CAGR | +26% | +23% | +15% | +13% |
| PAT CAGR | +25% | +38% | +25% | +20% |
| Share Price CAGR | -19% | +58% | +48% | +23% |
| ROE Average | +24% | +23% | +20% | +16% |
| ROCE Average | +31% | +29% | +26% | +21% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 |
| FII | 10.13 | 10.77 | 10.83 | 10.8 | 10.63 | 9.73 | 9.32 | 7.94 | 8.15 | 7.91 |
| DII | 1.61 | 1.58 | 1.95 | 2.02 | 2.03 | 3.33 | 3.9 | 4.14 | 4.23 | 3.31 |
| Public | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 11.32 | 11.32 | 11.32 |
| FII | 0.53 | 0.56 | 0.56 | 0.56 | 0.55 | 0.51 | 0.48 | 1.24 | 1.27 | 1.23 |
| DII | 0.08 | 0.08 | 0.1 | 0.1 | 0.11 | 0.17 | 0.2 | 0.65 | 0.66 | 0.52 |
| Public | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 4.28 | 4.28 | 4.28 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 15.6 | 15.6 | 15.6 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.